Who owns Xenon Pharmaceuticals Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of XENE from SEC Form 13F filings across 286 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 286 institutions disclosed 100.2M shares of Xenon Pharmaceuticals Inc. worth $3.73B — about 100.4% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
286
13F holders
$3.73B
value, 2026 filers
100.4%
of shares outstanding (100.2M sh)
35
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of XENE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 11.6M | $429.7M | 0.0% | 11.6% | +19.8% |
| 2 | T. Rowe Price Investment Management, Inc. | 7.9M | $293.7M | 0.2% | 7.9% | +264.1% |
| 3 | BlackRock, Inc. | 7.7M | $286.8M | 0.0% | 7.7% | +2.5% |
| 4 | Avoro Capital Advisors LLC | 5.5M | $204.5M | 2.1% | 5.5% | -4.8% |
| 5 | Polar Capital Holdings Plc | 5.0M | $186.8M | 0.5% | 5% | +9.9% |
| 6 | Janus Henderson Group Ltd.NEW | 4.0M | $148.8M | 0.1% | 4% | new |
| 7 | Driehaus Capital Management LLC | 3.6M | $132.3M | 0.9% | 3.6% | -19.5% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.2M | $118.2M | 0.0% | 3.2% | -2.1% |
| 9 | Capital International Investors | 2.4M | $87.8M | 0.0% | 2.4% | -0.1% |
| 10 | STATE STREET CORP | 2.1M | $76.5M | 0.0% | 2.1% | +4.5% |
| 11 | Affinity Asset Advisors, LLC | 1.9M | $70.7M | 2.9% | 1.9% | +19.1% |
| 12 | WESTFIELD CAPITAL MANAGEMENT CO LP | 1.8M | $66.2M | 0.2% | 1.8% | +18.0% |
| 13 | BRAIDWELL LP | 1.7M | $63.5M | 2.6% | 1.7% | +51.0% |
| 14 | DEERFIELD MANAGEMENT COMPANY, L.P. | 1.6M | $60.1M | 0.9% | 1.6% | 0.0% |
| 15 | WELLINGTON MANAGEMENT GROUP LLP | 1.5M | $55.1M | 0.0% | 1.5% | +3.9% |
| 16 | Pictet Asset Management Holding SA | 1.5M | $54.6M | 0.1% | 1.5% | +23.6% |
| 17 | FRANKLIN TEMPLETON INC | 1.4M | $56.6M | 0.0% | 1.4% | +0.5% |
| 18 | TWO SIGMA INVESTMENTS, LP | 1.4M | $53.7M | 0.0% | 1.4% | -12.2% |
| 19 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $51.5M | 0.0% | 1.4% | +1.2% |
| 20 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.3M | $50.0M | 0.0% | 1.3% | +4.2% |
| 21 | Point72 Asset Management, L.P. | 1.2M | $44.3M | 0.0% | 1.2% | +812.9% |
| 22 | BANK OF AMERICA CORP /DE/ | 1.0M | $38.6M | 0.0% | 1% | +157.0% |
| 23 | FEDERATED HERMES, INC. | 1.0M | $38.0M | 0.1% | 1% | +15.6% |
| 24 | AMERICAN CENTURY COMPANIES INC | 957,602 | $35.6M | 0.0% | 1% | +8.3% |
| 25 | MARSHALL WACE, LLP | 897,509 | $33.4M | 0.0% | 0.9% | +30.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.